ResearcherMedical College of WisconsinNo recent work listed

Daniel J. Rowan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7830-2525; OpenAlex author ID A5045488327. Sources: OpenAlex.

Their work

Papers: 3 (first author 1, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 8

Papers, trials and grants by year

2019: 1 paper · 2020: 2 papers

Papers 3

Gross tumor size using the AJCC 8th ed. T staging criteria does not provide prognostic stratification for neoadjuvant treated pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.anndiagpath.2020.151485 ↗
Increased SPARC expression is associated with neoadjuvant therapy in resectable pancreatic ductal adenocarcinoma. First author DOI 10.1016/j.plabm.2020.e00171 ↗
Coexisting pancreatic serous cystadenoma and pancreatic ductal adenocarcinoma: A cytological-pathologic correlation with literature review. Co-author DOI 10.1016/j.anndiagpath.2019.07.006 ↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Catherine E. Hagen · 2 shared papers, 2019–2020 · strength 0.26
- Paper Coexisting pancreatic serous cystadenoma and pancreatic ductal adenocarcinoma: A cytological-pathologic correlation wit… DOI 10.1016/j.anndiagpath.2019.07.006 ↗
- Paper Gross tumor size using the AJCC 8th ed. T staging criteria does not provide prognostic stratification for neoadjuvant t… DOI 10.1016/j.anndiagpath.2020.151485 ↗
Christopher Hartley · 2 shared papers, 2020 · strength 0.25
- Paper Gross tumor size using the AJCC 8th ed. T staging criteria does not provide prognostic stratification for neoadjuvant t… DOI 10.1016/j.anndiagpath.2020.151485 ↗
- Paper Increased SPARC expression is associated with neoadjuvant therapy in resectable pancreatic ductal adenocarcinoma. DOI 10.1016/j.plabm.2020.e00171 ↗
Tamara Giorgadze · 1 shared paper, 2019 · strength 0.14
- Paper Coexisting pancreatic serous cystadenoma and pancreatic ductal adenocarcinoma: A cytological-pathologic correlation wit… DOI 10.1016/j.anndiagpath.2019.07.006 ↗
Alexander Craig Mackinnon · 1 shared paper, 2020 · strength 0.13
- Paper Increased SPARC expression is associated with neoadjuvant therapy in resectable pancreatic ductal adenocarcinoma. DOI 10.1016/j.plabm.2020.e00171 ↗
Mohammed Aldakkak · 1 shared paper, 2020 · strength 0.13
- Paper Gross tumor size using the AJCC 8th ed. T staging criteria does not provide prognostic stratification for neoadjuvant t… DOI 10.1016/j.anndiagpath.2020.151485 ↗
Douglas B. Evans · 1 shared paper, 2020 · strength 0.13
- Paper Gross tumor size using the AJCC 8th ed. T staging criteria does not provide prognostic stratification for neoadjuvant t… DOI 10.1016/j.anndiagpath.2020.151485 ↗
Susan Tsai · 1 shared paper, 2020 · strength 0.13
- Paper Gross tumor size using the AJCC 8th ed. T staging criteria does not provide prognostic stratification for neoadjuvant t… DOI 10.1016/j.anndiagpath.2020.151485 ↗
Kathleen K. Christians · 1 shared paper, 2020 · strength 0.13
- Paper Gross tumor size using the AJCC 8th ed. T staging criteria does not provide prognostic stratification for neoadjuvant t… DOI 10.1016/j.anndiagpath.2020.151485 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.